Defining high, medium and low impact prognostic factors for developing multiple sclerosis
- PMID: 25902415
- DOI: 10.1093/brain/awv105
Defining high, medium and low impact prognostic factors for developing multiple sclerosis
Abstract
Natural history studies have identified factors that predict evolution to multiple sclerosis or risk of disability accumulation over time. Although these studies are based on large multicentre cohorts with long follow-ups, they have limitations such as lack of standardized protocols, a retrospective data collection or lack of a systematic magnetic resonance imaging acquisition and analysis protocol, often resulting in failure to take magnetic resonance and oligoclonal bands into account as joint covariates in the prediction models. To overcome some of these limitations, the aim of our study was to identify and stratify baseline demographic, clinical, radiological and biological characteristics that might predict multiple sclerosis development and disability accumulation using a multivariate approach based on a large prospective cohort of patients with clinically isolated syndromes. From 1995 to 2013, 1058 patients with clinically isolated syndromes were included. We evaluated the influence of baseline prognostic factors on the risk for developing clinically definite multiple sclerosis, McDonald multiple sclerosis, and disability accumulation (Expanded Disability Status Scale score of 3.0) based on univariate (hazard ratio with 95% confidence intervals) and multivariate (adjusted hazard ratio with 95% confidence intervals) Cox regression models. We ultimately included 1015 patients followed for a mean of 81 (standard deviation = 57) months. Female/male ratio was 2.1. Females exhibited a similar risk of conversion to multiple sclerosis and of disability accumulation compared to males. Each younger decade at onset was associated with a greater risk of conversion to multiple sclerosis and with a protective effect on disability. Patients with optic neuritis had a lower risk of clinically definite multiple sclerosis [hazard ratio 0.6 (0.5-0.8)] and disability progression [hazard ratio 0.5 (0.3-0.8)]; however, this protective effect remained marginal only for disability [adjusted hazard ratio 0.6 (0.4-1.0)] in adjusted models. The presence of oligoclonal bands increased the risk of clinically definite multiple sclerosis [adjusted hazard ratio 1.3 (1.0-1.8)] and of disability [adjusted hazard ratio 2.0 (1.2-3.6)] independently of other factors. The presence of 10 or more brain lesions on magnetic resonance increased the risk of clinically definite multiple sclerosis [adjusted hazard ratio 11.3 (6.7-19.3)] and disability [adjusted hazard ratio 2.9 (1.4-6.0)]. Disease-modifying treatment before the second attack reduced the risk of McDonald multiple sclerosis [adjusted hazard ratio 0.6 (0.4-0.9)] and disability accumulation [adjusted hazard ratio 0.5 (0.3-0.9)]. We conclude that the demographic and topographic characteristics are low-impact prognostic factors, the presence of oligoclonal bands is a medium-impact prognostic factor, and the number of lesions on brain magnetic resonance is a high-impact prognostic factor.
Keywords: clinically isolated syndromes; demyelination; epidemiology; imaging; multiple sclerosis.
© The Author (2015). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please email: journals.permissions@oup.com.
Similar articles
-
Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis?Neurology. 2008 Mar 25;70(13 Pt 2):1079-83. doi: 10.1212/01.wnl.0000280576.73609.c6. Epub 2007 Sep 19. Neurology. 2008. PMID: 17881717
-
Chitinase 3-like 1: prognostic biomarker in clinically isolated syndromes.Brain. 2015 Apr;138(Pt 4):918-31. doi: 10.1093/brain/awv017. Epub 2015 Feb 13. Brain. 2015. PMID: 25688078
-
Increased peripheral blood CD5+ B cells predict earlier conversion to MS in high-risk clinically isolated syndromes.Mult Scler. 2011 Jun;17(6):690-4. doi: 10.1177/1352458510396922. Epub 2011 Mar 24. Mult Scler. 2011. PMID: 21436320
-
Magnetic resonance imaging as a prognostic disability marker in clinically isolated syndrome: A systematic review.Acta Neurol Scand. 2019 Jan;139(1):18-32. doi: 10.1111/ane.13010. Epub 2018 Sep 6. Acta Neurol Scand. 2019. PMID: 30091223
-
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria.Lancet Neurol. 2018 Feb;17(2):162-173. doi: 10.1016/S1474-4422(17)30470-2. Epub 2017 Dec 21. Lancet Neurol. 2018. PMID: 29275977 Review.
Cited by
-
Importance of cerebrospinal fluid analysis in the era of McDonald 2010 criteria: a German-Austrian retrospective multicenter study in patients with a clinically isolated syndrome.J Neurol. 2016 Dec;263(12):2499-2504. doi: 10.1007/s00415-016-8302-1. Epub 2016 Oct 11. J Neurol. 2016. PMID: 27730374 Free PMC article.
-
Exploring miRNAs' Based Modeling Approach for Predicting PIRA in Multiple Sclerosis: A Comprehensive Analysis.Int J Mol Sci. 2024 Jun 7;25(12):6342. doi: 10.3390/ijms25126342. Int J Mol Sci. 2024. PMID: 38928049 Free PMC article.
-
Alemtuzumab in the treatment of multiple sclerosis: patient selection and special considerations.Drug Des Devel Ther. 2016 Oct 18;10:3379-3386. doi: 10.2147/DDDT.S97956. eCollection 2016. Drug Des Devel Ther. 2016. PMID: 27799738 Free PMC article. Review.
-
Frequency and immunophenotype of IL10-producing regulatory B cells in optic neuritis.Immunology. 2019 Mar;156(3):259-269. doi: 10.1111/imm.13024. Epub 2018 Dec 27. Immunology. 2019. PMID: 30452090 Free PMC article.
-
CSF parameters associated with early MRI activity in patients with MS.Neurol Neuroimmunol Neuroinflamm. 2019 May 30;6(4):e573. doi: 10.1212/NXI.0000000000000573. eCollection 2019 Jul. Neurol Neuroimmunol Neuroinflamm. 2019. PMID: 31355309 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical